HEALTH EQUITY IMPACTS OF ALTEPLASE FOR ISCHEMIC STROKE IN THE UNITED STATES: A DISTRIBUTIONAL COST-EFFECTIVENESS ANALYSIS

被引：0
|
作者：
Majda, T. [1 ]
Kowal, S. [1 ]
Mearns, E. S. [1 ]
Purdon, B. [1 ]
机构：
[1] Genentech Inc, South San Francisco, CA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
P14
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [1] TENECTEPLASE OR ALTEPLASE FOR ACUTE ISCHEMIC STROKE? A COST-EFFECTIVENESS ANALYSIS
    Nguyen, C.
    Lahr, M. M. H.
    Van der Zee, D. J.
    Van Voorst, H.
    Roos, Y. B. W. E. M.
    Uyttenboogaart, M.
    Buskens, E.
    VALUE IN HEALTH, 2022, 25 (12) : S167 - S167
  • [2] Distributional Cost-Effectiveness Analysis: Quantifying Health Equity Impacts and Trade-Offs
    Sinclair, Sean Campbell
    ETHICAL THEORY AND MORAL PRACTICE, 2021, 24 (04) : 1065 - 1068
  • [3] Improving health equity and ending the HIV epidemic in the United States: a distributional cost-effectiveness analysis in six cities
    Quan, A. M. L.
    Mah, C.
    Krebs, E.
    Zang, X.
    Chen, S.
    Althoff, K.
    Armstrong, W.
    Behrends, C. N.
    Dombrowski, J.
    Enns, E.
    Feaster, D. J.
    Gebo, K.
    Goedel, W.
    Golden, M.
    Marshall, B. D. L.
    Mehta, S.
    Pandya, A.
    Schackman, B. R.
    Strathdee, S.
    Sullivan, P.
    Tookes, H.
    Nosyk, B.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24 : 51 - 52
  • [4] The Impact of Funding Inpatient Treatments for COVID-19 on Health Equity in the United States: A Distributional Cost-Effectiveness Analysis
    Kowal, Stacey
    Ng, Carmen D.
    Schuldt, Robert
    Sheinson, Daniel
    Cookson, Richard
    VALUE IN HEALTH, 2023, 26 (02) : 216 - 225
  • [5] Analysis of the Cost-Effectiveness of Thrombolysis with Alteplase in Stroke
    Araujo, Denizar Vianna
    Teich, Vanessa
    Freitas Passos, Roberta Benitez
    Ouriques Martins, Sheila Cristina
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2010, 95 (01) : 12 - 19
  • [6] COST-EFFECTIVENESS ANALYSIS OF TENECTEPLASE VS ALTEPLASE FOR TREATMENT OF ACUTE ISCHEMIC STROKE
    Dasari, D.
    Deshmukh, A. A.
    VALUE IN HEALTH, 2020, 23 : S268 - S268
  • [7] Cost-effectiveness of tenecteplase versus alteplase for acute ischemic stroke
    Nguyen, Chi
    Lahr, Maarten M. H.
    Van Der Zee, Durk Jouke
    Van Voorst, Henk
    Roos, Yvo
    Uyttenboogaart, Maarten
    Buskens, Erik
    MEDICAL DECISION MAKING, 2024, 44 (02) : NP121 - NP122
  • [8] Cost-effectiveness of tenecteplase versus alteplase for acute ischemic stroke
    Nguyen, Chi Phuong
    Lahr, Maarten M. H.
    van der Zee, Durk-Jouke
    van Voorst, Henk
    Roos, Yvo B. W. E. M.
    Uyttenboogaart, Maarten
    Buskens, Erik
    CONTRAST Consortium
    EUROPEAN STROKE JOURNAL, 2023, 8 (03) : 638 - 646
  • [9] COST-EFFECTIVENESS OF THROMBOLYSIS WITH ALTEPLASE IN PATIENTS WITH ACUTE ISCHEMIC STROKE IN SLOVAKIA
    Blazinska, L.
    Psota, M.
    Spitzerova, H.
    Psenkova, M.
    VALUE IN HEALTH, 2019, 22 : S596 - S596
  • [10] THE HEALTH EQUITY IMPACT OF A HYPOTHETICAL DISEASE-MODIFYING TREATMENT FOR ALZHEIMER'S DISEASE IN THE UNITED STATES: A DISTRIBUTIONAL COST-EFFECTIVENESS ANALYSIS
    Synnott, P.
    Lin, P. J.
    Ollendorf, D.
    Zhu, Y.
    Majda, T.
    Kowal, S.
    VALUE IN HEALTH, 2024, 27 (06) : S72 - S72
12345